CLASS II HLA EPLET MISMATCH IS RELATED TO ANTI-DONOR CD4+ T CELL RESPONSE AND DE NOVO DONOR-SPECIFIC ANTIBODY DEVELOPMENT IN KIDNEY TRANSPLANTATION RECIPIENT